Kymera Therapeutics

@KymeraTx

Advancing the field of targeted protein degradation to deliver breakthrough medicines for previously untreatable diseases

Cambridge, MA
Vrijeme pridruživanja: svibanj 2017.

Tweetovi

Blokirali ste korisnika/cu @KymeraTx

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KymeraTx

  1. prije 7 sati

    Check out this story on targeted protein degradation: a powerful and practical new approach to address inflammation, the underlying driver of many hard-to-treat diseases.

    Poništi
  2. prije 11 sati

    Our team is in Greece this week to present preclinical data for our IRAK4 degrader program at the 9th Conference of the European Hidradenitis Suppurativa Foundation. Learn more about our findings.

    Poništi
  3. prije 13 sati

    Today Kymera shared preclinical data showing our oral protein degraders completely suppress IRAK4 expression in skin and immune cells and inhibit cutaneous inflammation. And we named as our first inflammation/immunology disease indication!

    Poništi
  4. 28. sij

    We're heading to San Diego for the warmer weather and the North American Protein Degradation Congress! Chris De Savi, PhD, will present on the promise of targeted protein degradation and the development of our first-in-class IRAK4 protein degraders.

    Poništi
  5. 23. sij

    Stop by and learn how we are advancing our STAT3 degraders into the clinic & expanding the biological impact of STAT3 degradation in liquid and solid tumors.

    Poništi
  6. 16. sij

    Our proprietary technology platform, Pegasus, advances our understanding of the partnering of E3 ligases and targets in order to optimize target degradation. Learn more:

    Poništi
  7. proslijedio/la je Tweet
    12. sij

    Excited for the 3rd official JPM. Big plans for us this year on both science and business. So honored to represent with Jared (CMO) and Bruce (CFO) our amazing team in the next few days. Connect with us in SF.

    Poništi
  8. 6. sij

    We’re hiring! Learn more about the Group Leader, Platform Biology role and our other openings:

    Poništi
  9. 1. sij

    Happy New Year! In 2020, we'll continue to pioneer and define the parameters that can transform the ubiquitin proteasome system into a small molecule-directed protein degradation therapeutic platform with applications across most, if not all, diseases.

    Poništi
  10. 20. pro 2019.

    Our team celebrated many great milestones this year and we're excited for our next chapter in 2020! Have a happy holiday season from all of us at Kymera!

    Poništi
  11. 18. pro 2019.

    We're hiring a Project Lead in Immunology! Serve as a leader and architect at a growing biotech company. Define and implement strategy to deliver meaningful medicines to patients with limited or no options. Learn more about the role:

    Poništi
  12. 11. pro 2019.

    Celebrating a key milestone at the Kymera office!

    Poništi
  13. 9. pro 2019.

    “These data highlight the potential for STAT3 degraders to treat STAT3-dependent lymphomas and leukemias," says Dr. Jared Gollob, our CMO. Read more about our Presentation and latest data package:

    Poništi
  14. 6. pro 2019.

    The team is heading to Orlando! We'll be presenting a poster at on Monday, December 9th at 6:00pm EST. We hope to see you there!

    Poništi
  15. 5. pro 2019.

    Kymera's Pegasus platform is a powerful engine discovering novel protein degraders that target and disrupt protein complexes and full signaling cascades, placing once elusive disease pathways within our reach. Learn more:

    Poništi
  16. 2. pro 2019.

    "We have enough examples out there that we can make these molecules look like drugs or act like drugs. People feel now is really the time to double down." , our CEO, in 's "Year in Pharma 2019":

    Poništi
  17. 28. stu 2019.

    Wishing everyone a Happy Thanksgiving from the Kymera team!

    Poništi
  18. 27. stu 2019.

    We have an exciting line up of presentations in Dec! Next week, we'll be sharing our story at the 31st Annual @PiperJaffrayCo Healthcare Conference and the Evercore ISI 2nd Annual HealthCONx Conference. will present on our innovative technology & pipeline progress.

    Poništi
  19. proslijedio/la je Tweet
    20. stu 2019.

    Thrilled to have step into the CEO role at ! Looking forward to great things under his continued and now expanded leadership!

    Poništi
  20. 20. stu 2019.

    We're thrilled to announce has been appointed as Kymera's Chief Executive Officer! Read more about this exciting milestone:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·